EP 1404336 A1 20040407 - COMPOSITIONS COMPRISING CGMPPDE5 INHIBITOR FOR TRANSDERMAL DELIVERY TO THE ERECTILE TISSUE OF THE PENIS
Title (en)
COMPOSITIONS COMPRISING CGMPPDE5 INHIBITOR FOR TRANSDERMAL DELIVERY TO THE ERECTILE TISSUE OF THE PENIS
Title (de)
ZUSAMMENSETZUNGEN ENTHALTEND CGMP-PDE5-HEMMAR ZUR TRANSDERMALEN VERABREICHUNG ZUR EREKTILGEWEBE DES PENISES
Title (fr)
COMPOSITIONS COMPRENANT UN INHIBITEUR DE CGMP PDE5 POUR ADMINISTRATION TRANSDERMIQUE AU TISSU ERECTILE DU PENIS
Publication
Application
Priority
- IN 0100210 W 20011127
- IN 551MU2001 A 20010614
- IN 552MU2001 A 20010614
Abstract (en)
[origin: WO02102385A1] The invention relates to a pharmaceutical composition comprising cyclic guanosine monophosphate phosphodiesterase type 5 (cGMP PDE5) inhibitor, sildenafil citrate, pharmaceutically acceptable solubilisers and penetration enhancers, along with thickening agents, buffers, emulsifiers and pharmaceutically acceptable surfactants and preservatives, for transdermal delivery to the erectile tissue of the penis, a process of preparing the said composition and method for treatment of erectile dysfunction / vasculogenic impotence by direct/topical application of the transdermal composition to the tissues covering the corpus cavernosum and to the glans penis. The transdermal delivery vehicle for topical application of the composition according to this invention may be in various forms such as gels, ointments, creams, lotions, emulsions and sprays.
IPC 1-7
IPC 8 full level
A61K 9/00 (2006.01); A61K 31/519 (2006.01); A61P 15/10 (2006.01)
CPC (source: EP)
A61K 9/0014 (2013.01); A61K 9/0034 (2013.01); A61K 31/519 (2013.01); A61P 15/10 (2017.12)
Citation (search report)
See references of WO 02102385A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
DOCDB simple family (application)
IN 0100210 W 20011127; EP 01274318 A 20011127